Advisory Resource Group Increases Stock Holdings in Intuitive Surgical, Inc. $ISRG

Advisory Resource Group raised its stake in shares of Intuitive Surgical, Inc. (NASDAQ:ISRG) by 5.3% during the second quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The firm owned 2,050 shares of the medical equipment provider’s stock after purchasing an additional 103 shares during the quarter. Advisory Resource Group’s holdings in Intuitive Surgical were worth $1,114,000 at the end of the most recent reporting period.

Several other institutional investors have also added to or reduced their stakes in ISRG. Tobam raised its stake in Intuitive Surgical by 666.7% in the second quarter. Tobam now owns 46 shares of the medical equipment provider’s stock worth $25,000 after buying an additional 40 shares in the last quarter. TD Capital Management LLC boosted its position in Intuitive Surgical by 300.0% during the 1st quarter. TD Capital Management LLC now owns 60 shares of the medical equipment provider’s stock valued at $30,000 after acquiring an additional 45 shares in the last quarter. 1248 Management LLC purchased a new position in shares of Intuitive Surgical during the 1st quarter worth approximately $30,000. Princeton Global Asset Management LLC bought a new position in shares of Intuitive Surgical in the 2nd quarter worth approximately $30,000. Finally, Bank of Jackson Hole Trust lifted its stake in shares of Intuitive Surgical by 70.5% in the 1st quarter. Bank of Jackson Hole Trust now owns 75 shares of the medical equipment provider’s stock valued at $37,000 after purchasing an additional 31 shares during the period. 83.64% of the stock is currently owned by institutional investors.

Intuitive Surgical Price Performance

Shares of NASDAQ:ISRG opened at $549.51 on Friday. Intuitive Surgical, Inc. has a 1 year low of $425.00 and a 1 year high of $616.00. The stock’s fifty day moving average price is $482.51 and its 200-day moving average price is $503.18. The company has a market cap of $196.99 billion, a P/E ratio of 72.69, a PEG ratio of 4.94 and a beta of 1.62.

Intuitive Surgical (NASDAQ:ISRG) last issued its earnings results on Tuesday, October 21st. The medical equipment provider reported $2.40 earnings per share for the quarter, topping analysts’ consensus estimates of $1.99 by $0.41. The business had revenue of $2.51 billion during the quarter, compared to analyst estimates of $2.41 billion. Intuitive Surgical had a return on equity of 15.08% and a net margin of 28.58%.Intuitive Surgical’s revenue was up 22.9% on a year-over-year basis. During the same quarter in the previous year, the firm earned $1.84 EPS. On average, sell-side analysts anticipate that Intuitive Surgical, Inc. will post 6.43 earnings per share for the current year.

Insider Activity

In related news, CEO David J. Rosa sold 24,500 shares of the stock in a transaction that occurred on Friday, October 24th. The shares were sold at an average price of $547.55, for a total transaction of $13,414,975.00. Following the transaction, the chief executive officer owned 234,256 shares in the company, valued at $128,266,872.80. This represents a 9.47% decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at the SEC website. Also, EVP Henry L. Charlton sold 13,731 shares of the firm’s stock in a transaction that occurred on Wednesday, November 12th. The stock was sold at an average price of $580.00, for a total transaction of $7,963,980.00. Following the completion of the sale, the executive vice president owned 3,056 shares in the company, valued at $1,772,480. This represents a 81.80% decrease in their position. The SEC filing for this sale provides additional information. Insiders sold 116,164 shares of company stock valued at $61,916,172 over the last three months. Corporate insiders own 0.70% of the company’s stock.

Analyst Upgrades and Downgrades

Several brokerages recently weighed in on ISRG. Erste Group Bank reaffirmed a “hold” rating on shares of Intuitive Surgical in a research note on Wednesday, July 23rd. The Goldman Sachs Group upped their target price on shares of Intuitive Surgical from $567.00 to $621.00 and gave the stock a “buy” rating in a research report on Wednesday, October 22nd. Deutsche Bank Aktiengesellschaft reissued a “sell” rating on shares of Intuitive Surgical in a research report on Friday, August 22nd. Argus upped their price objective on shares of Intuitive Surgical from $600.00 to $630.00 in a report on Monday, October 27th. Finally, Royal Bank Of Canada set a $625.00 target price on shares of Intuitive Surgical and gave the company an “outperform” rating in a research note on Wednesday, October 22nd. Two investment analysts have rated the stock with a Strong Buy rating, nineteen have assigned a Buy rating, seven have issued a Hold rating and one has given a Sell rating to the stock. According to MarketBeat, the company currently has a consensus rating of “Moderate Buy” and an average price target of $608.92.

Intuitive Surgical Profile

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.